El índice proteína C reactiva/albúmina como marcador para detectar colitis aguda ulcerosa grave en pacientes egipcios

Torres, 2012, Ulcerative colitis as a progressive disease: The forgotten evidence, Inflamm Bowel Dis., 18, 1356, 10.1002/ibd.22839 Peyrin-Biroulet, 2015, Selecting therapeutic targets in inflammatory bowel disease (STRIDE): Determining therapeutic goals for treat-to-target, Am J Gastroenterol., 110, 1324, 10.1038/ajg.2015.233 Truelove, 1954, Cortisone in ulcerative colitis; preliminary report on a therapeutic trial, Br Med J., 2, 375, 10.1136/bmj.2.4884.375 Rice-Oxley, 1950, Ulcerative colitis course and prognosis, Lancet., 255, 663, 10.1016/S0140-6736(50)90550-2 Miranda-García, 2016, Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease, Gastroenterol Hepatol., 39, 508, 10.1016/j.gastrohep.2016.01.015 Hindryckx, 2016, Acute severe ulcerative colitis: From pathophysiology to clinical management, Nat Rev Gastroenterol Hepatol., 13, 6546, 10.1038/nrgastro.2016.116 García-Bosch, 2016, Long-term follow-up of patients treated with infliximab for ulcerative colitis: Predictive factors of response-an observational study, Dig Dis Sci., 61, 2051, 10.1007/s10620-016-4089-2 Ranzani, 2013, C-reactive protein/albumin ratio predicts 90-day mortality of septic patients, PLoS One., 8, e59321, 10.1371/journal.pone.0059321 Osterman, 2016, Ulcerative Colitis, 2023 Xu, 2017, The prognostic value of C-reactive protein/albumin ratio in human malignancies: an up-dated meta-analysis, Onco Targets Ther., 10, 3059, 10.2147/OTT.S137002 Kaplan, 2017, Predictive value of C-reactive protein/albumin ratio in acute pancreatitis, Hepatobiliary Pancreat Dis Int., 16, 424, 10.1016/S1499-3872(17)60007-9 Ranzani, 2013, C-reactive protein/albumin ratio predicts 90-day mortality of septic patients, PLoS One., 8, e59321, 10.1371/journal.pone.0059321 Schroeder, 1987, Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study, N Engl J Med., 317, 1625, 10.1056/NEJM198712243172603 Bitton, 2012, Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements, Am J Gastroenterol., 107, 179, 10.1038/ajg.2011.386 Navaneethan, 2012, Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients, J Crohns Colitis., 6, 470, 10.1016/j.crohns.2011.10.005 Wu1, 2019, Serum procalcitonin as a potential early predictor of short-term outcomes in acute severe ulcerative colitis, Dig Dis Sci., 64, 3263, 10.1007/s10620-018-5446-0 Walsh, 2016, Current best practice for disease activity assessment in IBD, Nat Rev Gastroenterol Hepatol., 13, 567, 10.1038/nrgastro.2016.128 Iborra, 2016, Noninvasive testing for mucosal inflammation in inflammatory bowel disease, Gastrointest Endosc Clin N Am., 26, 641, 10.1016/j.giec.2016.06.005 Walsh, 2016, Current best practice for disease activity assessment in IBD, Nat Rev Gastroenterol Hepatol., 13, 567, 10.1038/nrgastro.2016.128 Vermeire, 2006, Laboratory markers in IBD: Useful, magic, or unnecessary toys?, Gut., 55, 426, 10.1136/gut.2005.069476 Chojkier, 2005, Inhibition of albumin synthesis in chronic diseases: Molecular mechanisms, J Clin Gastroenterol., 39, S143, 10.1097/01.mcg.0000155514.17715.39 Don, 2004, Serum albumin: Relationship to inflammation and nutrition, Semin Dial., 17, 432, 10.1111/j.0894-0959.2004.17603.x Tominaga, 2016, The C-reactive protein to albumin ratio as a predictor of severe side effects of adjuvant chemotherapy in stage III colorectal cancer patients, PLoS One., 11, e0167967, 10.1371/journal.pone.0167967 Karoui, 2011, Correlation of C-reactive protein with clinical and endoscopic activity in patients with ulcerative colitis, Dig Dis Sci., 56, 1801, 10.1007/s10620-010-1496-7 Hindryckx, 2016, Acute severe ulcerative colitis: From pathophysiology to clinical management, Nat Rev Gastroenterol Hepatol., 13, 654, 10.1038/nrgastro.2016.116 Sayar, 2020, A practical marker to determining acute severe ulcerative colitis: CRP/albumin ratio, North Clin Istanb., 7, 49 Gibson, 2018, CRP/Albumin ratio: An early predictor of steroid responsiveness in acute severe ulcerative colitis, J Clin Gastroenterol., 52, e48, 10.1097/MCG.0000000000000884 Chen, 2020, The relationship between C-reactive protein/albumin ratio and disease activity in patients with inflammatory bowel disease, Gastroenterol Res Pract., 22, 3467419